Willemse PH - Search Results

1

Intraperitoneal cisplatin versus no further treatment: 8-year results of EORTC 55875, a randomized phase III study in ovarian cancer patients with a pathologically complete remission after platinum-based intravenous chemotherapy.

Piccart MJ, Floquet A, Scarfone G, Willemse PH, Emerich J, Vergote I, Giurgea L, Coens C, Awada A, Vermorken JB. Piccart MJ, et al. Among authors: willemse ph. Int J Gynecol Cancer. 2003 Nov-Dec;13 Suppl 2:196-203. doi: 10.1111/j.1525-1438.2003.13360.x. Int J Gynecol Cancer. 2003. PMID: 14656280 Clinical Trial.

2

Phase II clinical trial of doxifluridine in patients with advanced ovarian cancer.

van Oosterom AT, ten Bokkel Huinink WW, van der Burg ME, Vermorken JB, Willemse PH, Neijt JP. van Oosterom AT, et al. Among authors: willemse ph. Eur J Cancer. 1991;27(6):747-9. doi: 10.1016/0277-5379(91)90180-l. Eur J Cancer. 1991. PMID: 1829917

3

Long-term survival in ovarian cancer. Mature data from The Netherlands Joint Study Group for Ovarian Cancer.

Neijt JP, ten Bokkel Huinink WW, van der Burg ME, van Oosterom AT, Willemse PH, Vermorken JB, van Lindert AC, Heintz AP, Aartsen E, van Lent M, et al. Neijt JP, et al. Among authors: willemse ph. Eur J Cancer. 1991;27(11):1367-72. doi: 10.1016/0277-5379(91)90011-2. Eur J Cancer. 1991. PMID: 1835850 Clinical Trial.

4

Randomized trial comparing two combination chemotherapy regimens (CHAP-5 v CP) in advanced ovarian carcinoma.

Neijt JP, ten Bokkel Huinink WW, van der Burg ME, van Oosterom AT, Willemse PH, Heintz AP, van Lent M, Trimbos JB, Bouma J, Vermorken JB, et al. Neijt JP, et al. Among authors: willemse ph. J Clin Oncol. 1987 Aug;5(8):1157-68. doi: 10.1200/JCO.1987.5.8.1157. J Clin Oncol. 1987. PMID: 3114434 Clinical Trial.

5

[Epithelial ovarian cancer (advanced stage): consensus conference (1998)].

Berek JS, Bertelsen K, du Bois A, Brady MF, Carmichael J, Eisenhauer EA, Gore M, Grenman S, Hamilton TC, Hansen SW, Harper PG, Horvath G, Kaye SB, Lück HJ, Lund B, McGuire WP, Neijt JP, Ozols RF, Parmar MK, Piccart-Gebhart MJ, van Rijswijk R, Rosenberg P, Rustin GJ, Sessa C, Thigpen JT, Tropé C, Tuxen MK, Vergote I, Vermorken JB, Willemse PH. Berek JS, et al. Among authors: willemse ph. Gynecol Obstet Fertil. 2000 Jul-Aug;28(7-8):576-83. Gynecol Obstet Fertil. 2000. PMID: 10996969 Review. French. No abstract available.

6

A phase II study of sabarubicin (MEN-10755) as second line therapy in patients with locally advanced or metastatic platinum/taxane resistant ovarian cancer.

Caponigro F, Willemse P, Sorio R, Floquet A, van Belle S, Demol J, Tambaro R, Comandini A, Capriati A, Adank S, Wanders J. Caponigro F, et al. Invest New Drugs. 2005 Jan;23(1):85-9. doi: 10.1023/B:DRUG.0000047110.36382.45. Invest New Drugs. 2005. PMID: 15528985 Clinical Trial.

7

Safety and pharmacology of paclitaxel in patients with impaired liver function: a population pharmacokinetic-pharmacodynamic study.

Joerger M, Huitema AD, Huizing MT, Willemse PH, de Graeff A, Rosing H, Schellens JH, Beijnen JH, Vermorken JB. Joerger M, et al. Among authors: willemse ph. Br J Clin Pharmacol. 2007 Nov;64(5):622-33. doi: 10.1111/j.1365-2125.2007.02956.x. Br J Clin Pharmacol. 2007. PMID: 17935602 Free PMC article.

8

Hepatic metabolism of paclitaxel and its impact in patients with altered hepatic function.

Panday VR, Huizing MT, Willemse PH, De Graeff A, ten Bokkel Huinink WW, Vermorken JB, Beijnen JH. Panday VR, et al. Among authors: willemse ph. Semin Oncol. 1997 Aug;24(4 Suppl 11):S11-34-S11-38. Semin Oncol. 1997. PMID: 9314297 Review.

9

Intraperitoneal chemotherapy in ovarian cancer.

Hofstra LS, de Vries EG, Mulder NH, Willemse PH. Hofstra LS, et al. Among authors: willemse ph. Cancer Treat Rev. 2000 Apr;26(2):133-43. doi: 10.1053/ctrv.1999.0152. Cancer Treat Rev. 2000. PMID: 10772970

10

Heat-shock-protein-27 (hsp27) expression in ovarian carcinoma: relation in response to chemotherapy and prognosis.

Arts HJ, Hollema H, Lemstra W, Willemse PH, De Vries EG, Kampinga HH, Van der Zee AG. Arts HJ, et al. Among authors: willemse ph. Int J Cancer. 1999 Jun 21;84(3):234-8. doi: 10.1002/(sici)1097-0215(19990621)84:3<234::aid-ijc6>3.0.co;2-9. Int J Cancer. 1999. PMID: 10371339 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

244 results

Search Page